{"id":"W3133949928","doi":"10.1016/j.eururo.2021.02.031","title":"Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"ca_institutions":"Public Health Ontario; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital; McMaster University; Centre for Probe Development and Commercialization; Women's College Hospital","funders":"Terry Fox Research Institute; University of Toronto; Princess Margaret Cancer Foundation; AbbVie","keywords":"Medicine; Prostatectomy; Prostate cancer; Clinical endpoint; SABR volatility model; Urology; Radiation therapy; Biochemical recurrence; Metastasis; Prostate-specific antigen; Prostate; Stage (stratigraphy); Androgen deprivation therapy; Phases of clinical research; Oncology; Cancer; Surgery; Internal medicine; Clinical trial; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006859966,0.0003847145,0.0006401657,0.0001620084,0.0005503769,0.00007496954,0.0002174709,0.00005074223,0.0001543804],"category_scores_gemma":[0.001854161,0.0002384447,0.0003108667,0.0007524201,0.0003226532,0.00007715954,0.000200463,0.0003891506,0.0000245954],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001574167,"about_ca_system_score_gemma":0.0004896478,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000370833,"about_ca_topic_score_gemma":0.00002192512,"domain_scores_codex":[0.9967089,0.0009636202,0.0005034418,0.0007555665,0.0003495992,0.0007188598],"domain_scores_gemma":[0.9974526,0.0007371699,0.0002277112,0.000498744,0.0009005414,0.0001832751],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1505638,0.007333718,0.002039251,0.0002605146,0.008781518,0.001895319,0.01215611,0.00003878542,0.07217246,0.001067676,0.006087379,0.7376035],"study_design_scores_gemma":[0.4872392,0.065487,0.01133212,0.0003496291,0.006708221,0.0007130021,0.003133353,0.002487501,0.1307061,0.002871387,0.2871045,0.001868022],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9077313,0.03262105,0.001091209,0.03663177,0.001162017,0.00924213,0.0007397528,0.0005796863,0.01020109],"genre_scores_gemma":[0.9914792,0.001131546,0.002448554,0.00132329,0.000414913,0.0014899,0.0001318702,0.0001087569,0.001471967],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7357355,"threshold_uncertainty_score":0.9723493,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0954410268437023,"score_gpt":0.3516837339162646,"score_spread":0.2562427070725622,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}